Linical Co., Ltd.
Research Linical Co., Ltd. (2183.T) on Bullrun: market cap JPY 4.52B, dividend yield 3.9%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2183.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyJPY
- Market capJPY 4.52B
- Dividend yield3.9%
- Financial periodFY2026
- RevenueJPY 8.67B
- Revenue growth-17.0%
- Net income-JPY 3.33B
- Free cash flow-JPY 1.64B
- Gross margin13.0%
Valuation Snapshot
latest market cap is JPY 4.52B; dividend yield is 3.9%.
Peer valuation comparison
Latest dividend yield is 3.9% versus a Healthcare sector median of 2.41% (61.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 8.67B | -JPY 3.33B | -JPY 1.64B | 13.0% | -147.41 | JPY 5.20B | JPY 2.25B | JPY 3.98B |
| FY2025 | JPY 10.44B | -JPY 539.10M | JPY 586.83M | 22.8% | -23.87 | JPY 7.04B | JPY 2.33B | JPY 7.25B |
| FY2024 | JPY 12.31B | JPY 338.27M | JPY 1.03B | 30.7% | 14.98 | JPY 7.47B | JPY 2.90B | JPY 8.24B |
| FY2023 | JPY 12.52B | JPY 1.00B | JPY 1.83B | 33.2% | 44.47 | JPY 7.04B | JPY 3.54B | JPY 7.58B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 4.52B | n/a | 4.0% | 8 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 8 JPY, yield 3.9%.
| Year | Dividends/share |
|---|---|
| FY2026 | 8 JPY |
| FY2025 | 16 JPY |
| FY2024 | 15 JPY |
| FY2023 | 14 JPY |
| FY2022 | 14 JPY |
About Linical Co., Ltd.
Linical Co., Ltd., a global contract research organization, provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug discovery consulting services, such as market analysis and research of products in development, regulatory affairs, and licensing support. It also provides clinical trial evaluation, statistical analysis, medical writing, pharmacovigilance, clinical monitoring, and contract medical affairs services.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Linical Co., Ltd.'s market cap?
Linical Co., Ltd.'s market capitalization is JPY 4.52B.
Does Linical Co., Ltd. pay a dividend?
Linical Co., Ltd. has a dividend yield of 3.9%.
What does Linical Co., Ltd. do?
Linical Co., Ltd., a global contract research organization, provides full spectrum of drug development services to pharmaceutical companies worldwide. The company offers drug discovery consulting services, such as market analysis and research of products in development, regulatory affairs, and licensing support. It also provides clinical trial evaluation, statistical analysis, medical writing, pharmacovigilance, clinical monitoring, and contract medical affairs services. The company was incorporated in 2005 and is headquartered in Osaka, Japan.